Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCF^Fbxl8

References

• Li Z, Van Calcar S, Qu C, Cavenee WK, Zhang MQ, Ren B. A global transcriptional regulatory role for c-Myc in Burkitt’s lymphoma cells. Proc Natl Acad Sci U S A. 2003;100(14):8164–8169. dio:10.1073/pnas.1332764100.
   PubMed Web of Science ®Google Scholar
• Delgado MD, Leon J. Myc roles in hematopoiesis and leukemia. Genes Cancer. 2010;1(6):605–616. dio:10.1177/1947601910377495.
   PubMedGoogle Scholar
• Madden SK, de Araujo AD, Gerhardt M, Fairlie DP, Mason JM. Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc. Mol Cancer. 2021;20(1):3. dio:10.1186/s12943-020-01291-6.
   PubMed Web of Science ®Google Scholar
• Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt’s lymphoma cells. Mol Cell Biol. 2000;20(7):2423–2435. dio:10.1128/MCB.20.7.2423-2435.2000.
   PubMed Web of Science ®Google Scholar
• Farrell AS, Sears RC. MYC degradation. Cold Spring Harb Perspect Med. 2014;4(3):a014365–a014365. dio:10.1101/cshperspect.a014365.
   PubMed Web of Science ®Google Scholar
• Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem. 2003;278(51):51606–51612. dio:10.1074/jbc.M310722200.
   PubMed Web of Science ®Google Scholar
• Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G, Hahn WC, Stukenberg PT, Shenolikar S, Uchida T, et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol. 2004;6(4):308–318. dio:10.1038/ncb1110
   PubMed Web of Science ®Google Scholar
• Grim JE, Gustafson MP, Hirata RK, Hagar AC, Swanger J, Welcker M, Hwang HC, Ericsson J, Russell DW, Clurman BE, et al. Isoform- and cell cycle-dependent substrate degradation by the Fbw7 ubiquitin ligase. J Cell Biol. 2008;181(6):913–920. dio:10.1083/jcb.200802076
   PubMed Web of Science ®Google Scholar
• Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, Clurman BE. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proc Natl Acad Sci U S A. 2004;101(24):9085–9090. dio:10.1073/pnas.0402770101.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Choi J, Jin HR, Li Y, Bajpai S, Qie S, Diehl JA. Fbxl8 suppresses lymphoma growth and hematopoietic transformation through degradation of cyclin D3. Oncogene. 2021;40(2):292–306. dio:10.1038/s41388-020-01532-4.
   PubMed Web of Science ®Google Scholar
• Bachireddy P, Bendapudi PK, Felsher DW. Getting at MYC through RAS. Clin Cancer Res. 2005;11(12):4278–4281. dio:10.1158/1078-0432.CCR-05-0534.
   PubMed Web of Science ®Google Scholar
• Sears RC. The life cycle of C-myc: from synthesis to degradation. Cell Cycle. 2004;3(9):1133–1137. doi:10.4161/cc.3.9.1145.
   PubMed Web of Science ®Google Scholar
• Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, Ishida N, Okumura F, Nakayama K, Nakayama KI, et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J. 2004;23(10):2116–2125. dio:10.1038/sj.emboj.7600217
   PubMed Web of Science ®Google Scholar
• Facchini LM, Penn LZ. The molecular role of Myc in growth and transformation: recent discoveries lead to new insights. FASEB J. 1998;12(9):633–651. doi:10.1096/fasebj.12.9.633.
   PubMed Web of Science ®Google Scholar
• Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, Palmiter RD, Brinster RL. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985;318(6046):533–538. dio:10.1038/318533a0.
   PubMed Web of Science ®Google Scholar
• Kalkat M, De Melo J, Hickman KA, Lourenco C, Redel C, Resetca D, et al. MYC deregulation in primary human cancers. Genes (Basel). 2017;8(6):151. dio:10.3390/genes8060151
   PubMed Web of Science ®Google Scholar
• Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008. 8(12):976–990. dio:10.1038/nrc2231.
   PubMed Web of Science ®Google Scholar
• Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, Capra M, Goettig S, et al. The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell. 2005;123(3):409–421. dio:10.1016/j.cell.2005.08.016
   PubMed Web of Science ®Google Scholar
• Sato M, Rodriguez-Barrueco R, Yu J, Do C, Silva JM, Gautier J. MYC is a critical target of FBXW7. Oncotarget. 2015. 6(5):3292–3305. dio:10.18632/oncotarget.3203.
   PubMedGoogle Scholar
• Kim SY, Herbst A, Tworkowski KA, Salghetti SE, Tansey WP. Skp2 regulates Myc protein stability and activity. Mol Cell. 2003;11(5):1177–1188. dio:10.1016/s1097-2765(03)00173-4.
   PubMed Web of Science ®Google Scholar
• Felsher DW. MYC inactivation elicits oncogene addiction through both tumor cell-intrinsic and host-dependent mechanisms. Genes Cancer. 2010. 1(6):597–604. dio:10.1177/1947601910377798.
   PubMedGoogle Scholar
• Mertz JA, Conery AR, Bryant BM, Sandy P, Balasubramanian S, Mele DA, Bergeron L, Sims RJ. Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A. 2011;108(40):16669–16674. dio:10.1073/pnas.1108190108.
   PubMed Web of Science ®Google Scholar
• Srinivasan SV, Dominguez-Sola D, Wang LC, Hyrien O, Gautier J. Cdc45 is a critical effector of myc-dependent DNA replication stress. Cell Rep. 2013;3(5):1629–1639. dio:10.1016/j.celrep.2013.04.002.
   PubMed Web of Science ®Google Scholar
• McMahon SB. MYC and the control of apoptosis. Cold Spring Harb Perspect Med. 2014;4(7):a014407. dio:10.1101/cshperspect.a014407.
   PubMed Web of Science ®Google Scholar
• Zhang T, Li N, Sun C, Jin Y, Sheng X. MYC and the unfolded protein response in cancer: synthetic lethal partners in crime? EMBO Mol Med. 2020;12(5):e11845. dio:10.15252/emmm.201911845.
   PubMed Web of Science ®Google Scholar
• Arabi A, Wu S, Ridderstrale K, Bierhoff H, Shiue C, Fatyol K, et al. c-Myc associates with ribosomal DNA and activates RNA polymerase I transcription. Nat Cell Biol. 2005;7(3):303–310. dio:10.1038/ncb1225
   PubMed Web of Science ®Google Scholar
• Cowling VH, Cole MD. The Myc transactivation domain promotes global phosphorylation of the RNA polymerase II carboxy-terminal domain independently of direct DNA binding. Mol Cell Biol. 2007;27(6):2059–2073. dio:10.1128/MCB.01828-06.
   PubMed Web of Science ®Google Scholar
• Nagy P, Varga A, Pircs K, Hegedus K, Juhasz G. Myc-driven overgrowth requires unfolded protein response-mediated induction of autophagy and antioxidant responses in Drosophila melanogaster. PLoS Genet. 2013;9(8):e1003664. dio:10.1371/journal.pgen.1003664.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. dio:10.1093/nar/gkx247.
   PubMed Web of Science ®Google Scholar
• Dong H, Wang Q, Zhang G, Li N, Yang M, An Y, Xie L, Li H, Zhang L, Zhu W, et al. OSdlbcl: an online consensus survival analysis web server based on gene expression profiles of diffuse large B-cell lymphoma. Cancer Med. 2020;9(5):1790–1797. dio:10.1002/cam4.2829
   PubMed Web of Science ®Google Scholar
• Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, Netto GJ, Qin ZS, Kumar S, Manne U, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18–27. dio:10.1016/j.neo.2022.01.001.
   PubMed Web of Science ®Google Scholar
• Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401–404. dio:10.1158/2159-8290.CD-12-0095
   PubMed Web of Science ®Google Scholar